Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1

Documenti analoghi

• De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum
  di: Xiao‐Yu Liang, et al.
  Pubblicazione: (2025)
• The epilepsy–autism phenotype associated with developmental and epileptic encephalopathies: New mechanism‐based therapeutic options
  di: Nicola Specchio, et al.
  Pubblicazione: (2025)
• Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy
  di: Machiko Iida, et al.
  Pubblicazione: (2024)
• Operational definition of developmental and epileptic encephalopathies to underpin the design of therapeutic trials
  di: Ingrid E. Scheffer, et al.
  Pubblicazione: (2025)
• Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies
  di: Heidrun Potschka, et al.
  Pubblicazione: (2025)